Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 996

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

Open access
Quesada, Víctor, Conde, Laura, Villamor, Neus, Ordóñez, Gonzalo R, Jares, Pedro, Bassaganyas, Laia, Ramsay, Andrew J, Beà, Sílvia, Pinyol, Magda, Martínez-Trillos, Alejandra, López-Guerra, Mónica, Colomer, Dolors, Navarro, Alba, Baumann, Tycho, Aymerich, Marta, Rozman, María, Delgado, Julio, Giné, Eva, Hernández, Jesús M, González-Díaz, Marcos, Puente, Diana A, Velasco, Gloria, Freije, José M P, Tubío, José M C, Royo, Romina, Gelpí, Josep L, Orozco, Modesto, Pisano, David G, Zamora, Jorge, Vázquez, Miguel, Valencia, Alfonso, Himmelbauer, Heinz, Bayés, Mónica, Heath, Simon, Gut, Marta, Gut, Ivo, Estivill, Xavier, López-Guillermo, Armando, Puente, Xose S, Campo, Elías, López-Otín, Carlos·2012·Nature Genetics

Abstract

Here we perform whole-exome sequencing of samples from 105 individuals with chronic lymphocytic leukemia (CLL), the most frequent leukemia in adults in Western countries. We found 1,246 somatic mutations potentially affecting gene function and identified 78 genes with predicted functional alterations in more than one tumor sample. Among these genes, SF3B1, encoding a subunit of the spliceosomal U2 small nuclear ribonucleoprotein (snRNP), is somatically mutated in 9.7% of affected individuals. Further analysis in 279 individuals with CLL showed that SF3B1 mutations were associated with faster disease progression and poor overall survival. This work provides the first comprehensive catalog of somatic mutations in CLL with relevant clinical correlates and defines a large set of new genes that may drive the development of this common form of leukemia. The results reinforce the idea that targeting several well-known genetic pathways, including mRNA splicing, could be useful in the treatment of CLL and other malignancies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ng.1032

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 996

Metadata

Authors
Quesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez-Trillos, A., López-Guerra, M., Colomer, D., Navarro, A., Baumann, T., Aymerich, M., Rozman, M., Delgado, J., Giné, E., Hernández, J. M., González-Díaz, M., Puente, D. A., Velasco, G., Freije, J. M. P., Tubío, J. M. C., Royo, R., Gelpí, J. L., Orozco, M., Pisano, D. G., Zamora, J., Vázquez, M., Valencia, A., Himmelbauer, H., Bayés, M., Heath, S., Gut, M., Gut, I., Estivill, X., López-Guillermo, A., Puente, X. S., Campo, E., & López-Otín, C.
Venue
Nature Genetics
Published
2011-12-11
Volume
44
Issue
1
Pages
47-52
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2031121711
Cited by
996
References
10
FWCI
46.79
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. https://app.cochat.ai/papers/10.1038/ng.1032
The paper
Quesada, V., Conde, L., Villamor, N., Ordóñez, G. R., Jares, P., Bassaganyas, L., Ramsay, A. J., Beà, S., Pinyol, M., Martínez-Trillos, A., López-Guerra, M., Colomer, D., Navarro, A., Baumann, T., Aymerich, M., Rozman, M., Delgado, J., Giné, E., Hernández, J. M., . . . López-Otín, C. (2012). Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nature Genetics. https://doi.org/10.1038/ng.1032

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.